Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Themis Medicare Ltd Financial Statements & Historical Data

Updated
Report details
Last Updated:
Author: |Social: XLinkedIn

Themis Medicare Ltd: Earnings returned to a reported profit of ₹25 crore in the quarter ending Jun 2026, compared with a loss of ₹14 crore in Jun 2025. Sales fell 11.2% to ₹87 crore against Jun 2025. Operating margin fell from -10.2% to -59.8% (49.6 percentage points lower). A reported annual profit of ₹1.00 crore coincided with an operating cash outflow of ₹3.00 crore in the year ending Mar 2026; the cash-flow reconciliation is important context for the earnings.

Calculated from the stored statements below · Reporting periods remain separate
COMPANY FINANCIAL DATA

Market snapshot

Stored figures, not live quotes. Price record: 15 October 2026, 9:56 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price106₹ per share
Reported P/ENot availableTimes
Book value per share43.3₹ per share
Reported ROCE2.74 %Reported return

Stored market and accounting figures

Price record: 15 October 2026, 9:56 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap979 Cr.
Current Price106
High / Low141/65.0
Stock P/ENot available
Book Value43.3
Dividend Yield0.47 %
ROCE2.74 %
ROE0.41 %
Face Value1.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

DAILY STORED OBSERVATIONS

Share price history

₹ per share

Last stored price for each available date, not a live quote or an official closing-price series. Missing dates are not filled. Verify corporate-action adjustments against the source.

Chart loads as you scroll.

EARNINGS

Quarterly performance

Jun 2026

Earnings returned to a reported profit of ₹25 crore in the quarter ending Jun 2026, compared with a loss of ₹14 crore in Jun 2025. Sales fell 11.2% to ₹87 crore against Jun 2025. Operating margin fell from -10.2% to -59.8% (49.6 percentage points lower). Less operating profit was retained from each rupee of sales; compare the expense rows before attributing the change to a cause. Prior-year profit was zero or negative; a conventional percentage growth comparison would be misleading.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Quarterly statementAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 97105839812311794729878907787
Expenses 75927489941008879108818073139
Operating Profit 22128929176-8-10-3104-52
OPM % 22%12%10%10%24%15%6%-11%-10%-4.0%11%4.9%-60%
Other Income 676576121561197
Interest 2232223223333
Depreciation 3333223333333
Profit before tax 23148931182-11-14-310939
Tax % 19%19%10%24%21%20%69%-13%1%5%3%2%36%
Net Profit 18117725141-10-14-410925
EPS in Rs 1.981.230.800.722.681.550.06-1.05-1.54-0.391.100.972.67

Last Updated: September 29, 2026, 5:07 pm

EARNINGS

Annual performance

Mar 2026

Both sales and earnings contracted in the year ending Mar 2026. Sales fell 15.8% to ₹342 crore against Mar 2025. Net profit fell 96.7% to ₹1.00 crore against the same period a year earlier. Operating margin fell from 12.1% to 0.0% (12.1 percentage points lower). Less operating profit was retained from each rupee of sales; compare the expense rows before attributing the change to a cause.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
PER-SHARE EARNINGS

Earnings per share

Reported annual earnings per share use ₹ per share, while the earnings charts use ₹ crore. Changes in share count and corporate actions can affect the comparison between years.

Earnings per share

₹ per share

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Annual statementAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 12, 2026, 4:47 am

MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 202232217210184202231395354382406342332
Expenses 184194184184181166181299287330356342374
Operating Profit 1838332523649966752490-42
OPM % 9%16%15%12%1.2%18%21%24%19%13%12%0.1%-13%
Other Income 13346512131825241123118
Interest 151212121213139109101111
Depreciation 11127788991012101010
Profit before tax 5171811-13274195735340255
Tax % -20%11%9%1%-15%8%14%23%22%19%25%40%
Net Profit 6161611-11253673574430140
EPS in Rs 0.731.911.771.23-1.172.703.887.926.184.733.240.124.35
Dividend Payout % 25%9%0%0%0%6%11%6%8%11%15%404%
Year-on-year profit growth table

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)166.67%0.00%-31.25%-200.00%327.27%44.00%102.78%-21.92%-22.81%-31.82%-96.67%
Change in YoY Net Profit Growth (%)0.00%-166.67%-31.25%-168.75%527.27%-283.27%58.78%-124.70%-0.89%-9.01%-64.85%

Growth

Compounded Sales Growth
10 Years:7%
5 Years:15%
3 Years:1%
TTM:-7%
Compounded Profit Growth
10 Years:17%
5 Years:4%
3 Years:-25%
TTM:-118%
Stock Price CAGR
10 Years:17%
5 Years:24%
3 Years:8%
1 Year:-59%
Return on Equity
10 Years:13%
5 Years:15%
3 Years:12%
Last Year:8%

Last Updated: September 5, 2025, 1:46 pm

CASH & FUNDING

Balance sheet

Mar 2026

Reported borrowings stood at ₹100 crore in Mar 2026. They increased from ₹83 crore in Mar 2025 (20.5% higher). Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Balance-sheet statementAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: July 24, 2026, 2:00 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 899999999999
Reserves 5166143160149174209278330368393389
Borrowings 1401288280821008780929683100
Other Liabilities 7773545674676561829310299
Total Liabilities 277275289305314350371428514566588598
Fixed Assets 122117124126123116133144162168172167
CWIP 469228233332
Investments 56232427354556708995109
Other Assets 146146133153162191191225279307318320
Total Assets 277275289305314350371428514566588598
CASH & FUNDING

Cash generation

Mar 2026

Operating activities used ₹3.00 crore in Mar 2026. Reported free cash flow for the same period was −₹8.00 crore. Negative operating cash flow means cash left the operating cycle; examine receivables, working capital and the reconciliation in the company filing before attributing a cause. A reported annual profit of ₹1.00 crore coincided with an operating cash outflow of ₹3.00 crore in the year ending Mar 2026; the cash-flow reconciliation is important context for the earnings.

Operating & free cash flow

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Cash-flow statementAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 1926-281105734162235-3
Cash from Investing Activity + -6-7-4-0-4-5-16-16-24-16-12-3
Cash from Financing Activity + -18-135-9-107-26-180-9-264
Net Cash Flow -55-0-1-32161-8-3-3-2
Free Cash Flow 1318-755-53915-13421-8
CFO/OP 101%73%-5%29%490%2%115%55%48%60%93%782%
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 101%73%-5%29%490%2%115%55%48%60%93%782%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow13.0018.00-7.005.005.00-5.0039.0015.00-13.004.0021.00-8.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

OPERATING CYCLE

Capital efficiency

Mar 2025

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Working-capital days were 121 in Mar 2025. That is 5 days higher than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
CAPITAL RETURNS

Returns on capital & equity

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Returns on capital & equity

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Efficiency tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 7482758112014518612393149170159
Inventory Days 280246243250253287315272150213188233
Days Payable 24023714516315618717114379123126142
Cash Conversion Cycle 11491172168216244330251164239232250
Working Capital Days -17-20-17-1619-1375172110116121
ROCE %10%9%15%13%10%-1%15%18%30%20%14%10%
SHAREHOLDERS

Ownership trends

Jun 2026

Promoters held 67.10% in Jun 2026. Their share was 0.05 percentage points lower than in Jun 2025. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction. FIIs held 0.01% in Jun 2026, 0.08 percentage points below their holding in Jun 2025. DIIs held 0.01% in Jun 2026, unchanged from their holding in Jun 2025.

Shareholding comparison

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
SHAREHOLDER PARTICIPATION

Shareholder count

Shareholder count

Shareholders

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Ownership tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 67.16%67.16%67.15%67.15%67.15%67.15%67.15%67.15%67.15%67.10%67.10%67.10%
FIIs 0.05%0.01%0.03%0.05%0.10%0.10%0.14%0.09%0.06%0.05%0.11%0.01%
DIIs 0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%
Public 32.77%32.82%32.81%32.79%32.74%32.75%32.70%32.75%32.77%32.84%32.78%32.87%
No. of Shareholders 6,97011,24411,29511,32214,27017,77317,88919,33522,49022,57621,81821,267
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Motilal Oswal S&P BSE Healthcare ETF 322 0.08 0.013222025-04-22 17:25:180%
ALTERNATE FEED

Financial ratios

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Each card groups related ratios with the same unit. Reporting dates remain visible for every measure; the original ratio table follows the charts.

ALTERNATE RATIO FEED

Profitability ratios

%

Profitability ratios

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Liquidity ratios

Multiple (×)

Liquidity ratios

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Distributions & retention

%

Distributions & retention

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Interest coverage

Multiple (×)

Interest coverage

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
ALTERNATE RATIO FEED

Valuation multiples

Multiple (×)

Valuation multiples

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting ratio tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.0010.0010.0010.00
Basic EPS (Rs.) 3.244.7361.8379.2238.86
Diluted EPS (Rs.) 3.244.7261.7379.0738.84
Cash EPS (Rs.) 3.684.0258.4477.1937.85
Book Value[Excl.RevalReserv]/Share (Rs.) 43.7441.03368.85312.48237.80
Book Value[Incl.RevalReserv]/Share (Rs.) 43.7441.03368.85312.48237.80
Revenue From Operations / Share (Rs.) 44.0641.48385.02428.91251.04
PBDIT / Share (Rs.) 5.846.1185.80111.0657.81
PBIT / Share (Rs.) 4.764.7874.39100.7548.50
PBT / Share (Rs.) 3.673.7664.0091.2234.67
Net Profit / Share (Rs.) 2.602.6947.0366.8928.54
NP After MI And SOA / Share (Rs.) 3.244.7361.8379.2238.86
PBDIT Margin (%) 13.2414.7322.2825.8923.02
PBIT Margin (%) 10.7911.5219.3223.4919.32
PBT Margin (%) 8.329.0716.6221.2613.81
Net Profit Margin (%) 5.896.4712.2115.5911.37
NP After MI And SOA Margin (%) 7.3511.4016.0518.4615.47
Return on Networth / Equity (%) 7.4111.5216.7625.3516.33
Return on Capital Employeed (%) 10.1310.6818.2629.1218.35
Return On Assets (%) 5.077.6811.0717.039.61
Long Term Debt / Equity (X) 0.040.070.080.080.10
Total Debt / Equity (X) 0.200.250.270.270.36
Asset Turnover Ratio (%) 0.700.700.751.050.67
Current Ratio (X) 1.951.901.901.961.45
Quick Ratio (X) 1.411.441.411.400.98
Inventory Turnover Ratio (X) 5.241.211.481.901.20
Dividend Payout Ratio (NP) (%) 15.4210.578.085.424.50
Dividend Payout Ratio (CP) (%) 11.578.256.824.803.63
Earning Retention Ratio (%) 84.5889.4391.9294.5895.50
Cash Earning Retention Ratio (%) 88.4391.7593.1895.2096.37
Interest Coverage Ratio (X) 5.356.008.2611.644.18
Interest Coverage Ratio (Post Tax) (X) 3.383.645.538.013.06
Enterprise Value (Cr.) 1419.922092.171146.53910.58312.04
EV / Net Operating Revenue (X) 3.505.483.242.311.35
EV / EBITDA (X) 26.4337.1914.528.915.87
MarketCap / Net Operating Revenue (X) 3.335.283.032.181.12
Retention Ratios (%) 84.5789.4291.9194.5795.49
Price / BV (X) 3.355.343.162.991.18
Price / Net Operating Revenue (X) 3.335.283.032.181.12
EarningsYield 0.020.020.050.080.13

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Themis Medicare Ltd 979 Cr. 106 141/65.0 43.30.47 %2.74 %0.41 % 1.00
Bafna Pharmaceuticals Ltd 1,091 Cr. 461 469/94.8140 40.60.00 %11.9 %12.3 % 10.0
Lincoln Pharmaceuticals Ltd 1,093 Cr. 546 770/44011.3 3780.33 %16.0 %12.0 % 10.0
Anuh Pharma Ltd 837 Cr. 83.7 99.5/66.719.0 35.11.79 %14.9 %10.7 % 5.00
Kilitch Drugs (India) Ltd 806 Cr. 230 268/11726.8 80.00.00 %13.4 %10.6 % 10.0
Industry Average17,083.24 Cr1,203.8146.72210.850.40%26.16%16.59%6.06

All Competitor Stocks of Themis Medicare Ltd

Explore Industry-wise Company financial data